During the past decade, Maison Medicale Marzet conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Maison Medicale Marzet" are "Gastric Cancer" (1 trials), "Lung Cancer" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Maison Medicale Marzet" in a lesser frequency.

Most popular intervention types in "Maison Medicale Marzet" are "Drug" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (1 trials), "carboplatin" (1 trials), "docetaxel" (1 trials), "epirubicin hydrochloride" (1 trials) and "gemcitabine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maison Medicale Marzet" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Maison Medicale Marzet". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Maison Medicale Marzet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maison Medicale Marzet, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".